Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bausch Health Companies Inc T.BHC

Alternate Symbol(s):  BHC

Healthcare Biotechnology
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

TSX:BHC - Post Discussion

Bausch Health Companies Inc > Bausch Eye
View:
Post by HopefulJuan on Aug 07, 2020 4:39am

Bausch Eye

Hoping to see the price set in the $10 US range or more. Now they will have two to short and control.
Comment by temeraire on Aug 07, 2020 12:07pm
Haha - part of the short offensive I guess!!   I think I'll take my chances that the split creates shareholder value beyond the present sp of 24.62 tmx.  You'd be best advise to add back now....   
Comment by LowtoHigh on Aug 27, 2020 10:38pm
I'm with you on that!
Comment by HopefulJuan on Aug 31, 2020 11:18am
You got me. A shorter on a board with 2 posts per month. What values do you see for the new companies? I thought Bausch Eye is 60%.  Valuations are ridiculous. Good news does not help. 
Comment by temeraire on Sep 01, 2020 9:30pm
Check out our he analysis done & posted on seeking alpha.  The real question is why it isn't taken Private and reengineered for considerably more than current valuation. 
Bausch Health Companies Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities